Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of 123.61 million as of January 23, 2025. Its market cap has decreased by -28.57% in one year.

Market Cap

123.61M

Enterprise Value

76.00M

Revenue

28.65M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.78

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 123.61M, an increase of 23,200.13%. That is a compound annual growth rate of 34.83%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	123.61M	-4.42%
Dec 31, 2024	129.34M	-29.44%
Dec 29, 2023	183.31M	-21.67%
Dec 30, 2022	234.02M	-20.77%
Dec 31, 2021	295.36M	20.59%
Dec 31, 2020	244.93M	-38.25%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shell	168.73B
AstraZeneca	167.37B
HSBC Holdings	145.28B
Unilever	113.90B
Rio Tinto Group	86.42B
RELX PLC	73.51B
BP p.l.c.	67.77B
British American Tobacco p.l.c.	65.16B

Market Cap Rankings